Are modern scalable bioreactors the right cell culture strategy for gene and cell therapy success?

The success of viral vector-based gene and cell therapy passes by rapid and smart scale-up technology, from development to production scale.

Modern scalable bioreactors represent strong candidates thanks to high degree of automation, monitoring features and low contamination risk.

This article will give you an overview of the platforms available on the market for both adherent and suspension cell culture.

Viral Vectored Gene therapies approved worldwide